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Main	Text
The	famous	1785	Robert	Burns	poem	“To	a	Mouse”	describes	how	a	mouse	carefully	builds	a	nest	in	a	wheat	field	only	to	have	it	destroyed	by	a	farmer’s	plough.	Including	the	renowned	phrase,	“the	best-laid	plans	of	mice	and
men	often	go	awry”;	this	poem	draws	parallels	with	a	report	from	Nicholson	et	al.	(2018,	this	issue	of	Cell	Stem	Cell)	that	human	and	mouse	intestinal	stem	cell	(ISC)	dynamics	differ	substantially.
Investigation	of	ISC	properties	have	provided	insights	into	tissue	homeostasis	and	disease.	However,	technical	constraints	largely	prohibit	direct	measurement	of	these	properties	in	humans,	and	as	such,	the	mouse	has	served
as	a	model	organism	to	unveil	the	complexities	of	stem	cell	competition.	Nicholson	et	al.	(2018)	report	that	human	ISCs	exhibit	substantially	different	dynamics	than	those	observed	in	mice	and	characterize	examples	of	mutations	that
can	distort	ISC	dynamics.
It	is	well	established	that	intestinal	crypts	contain	multiple	ISCs.	Mouse	ISC	studies	show	that	they	divide	daily	and	compete	randomly	for	limited	niche	space	at	the	crypt	base	via	the	process	of	neutral	drift	(Vermeulen	and
Snippert,	2014).	Neutral	drift	suggests	that	each	functional	ISC	has	an	equal	probability	(p	=	0.5)	of	replacing	its	neighbor,	and	thus	over	time,	a	crypt	will	drift	toward	monoclonality	and	become	“fixed.”	At	the	clonal	level,	stochastic
competition	between	ISCs	provides	an	opportunity	for	clonal	progeny	to	expand	or	retract,	either	displacing	the	ISC-clones	from	the	crypt	or	resulting	in	crypt	fixation.	Somatic	mutations	in	genes	such	as	Apc	or	Kras,	or	changes	to
the	ISC	niche	such	as	reduced	Wnt	ligand	secretion	(Huels	et	al.,	2018),	alter	competition	between	ISCs.	Mutant	ISCs	can	have	a	greater	chance	of	displacing	non-mutant	ISCs,	thus	increasing	the	probability	of	mutant	crypt	fixation,
a	key	requirement	for	pervasive	cell	transformation	(Snippert	et	al.,	2014;	Vermeulen	et	al.,	2013).
Nicholson	et	al.	(2018)	define	baseline	human	ISC	dynamics	by	looking	for	known	spontaneous	mutations	that	continuously	label	ISCs	in	the	human	colon.	One	such	mutation	is	in	the	gene	that	encodes	the	enzyme	O-acetyl
transferase	(OAT),	the	absence	of	which	is	visualized	via	mild	Periodic	acid-Schiff	(mPAS)	staining.	Loss	of	O-acetylation	of	sialomucins	in	patient	colonic	epithelium	(mPAS+)	was	detected	using	automated	image	analyses.	This	revealed
that	the	number	of	partially	populated	crypts	(PPCs)	remains	constant	over	time	in	accordance	with	the	theory	of	neutral	drift,	whereas	the	number	of	wholly	populated	crypts	(WPCs)	increased	with	age,	suggesting	that	a	PPC	can
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either	become	fixed	or	be	replaced	(Figure	1).	Using	this	knowledge,	the	authors	determine	that	the	average	time	to	monoclonality	in	a	human	colonic	crypt	is	6.3	years,	a	pedestrian	pace	when	compared	with	mouse	crypts,	where
monoclonality	can	be	reached	in	a	matter	of	weeks.	A	recent	corroborating	report	uses	mathematical	modeling	to	infer	that	human	colonic	ISCs	predominantly	undergo	asymmetric	cell	division,	accounting	for	the	leisurely	pace	of
crypt	fixation	(Stamp	et	al.,	2018).
To	determine	the	de	novo	mutation	rate,	Nicholson	et	al.	(2018)	stained	serial	sections	to	identify	single-cell	clones	and	used	this	information	to	infer	baseline	stem	cell	behaviors.	The	authors	conclude	that	human	colonic
crypts	contain	an	average	of	7	ISCs	(Ncrypt)	that	replace	each	other	∼1.3	times/yr/crypt	(λcrypt),	a	rate	that	is	approximately	two	orders	of	magnitude	lower	than	that	of	mouse	ISCs	(Kozar	et	al.,	2013).	Other	reports	have	calculated	a
comparable	number	of	ISCs	per	crypt	(Baker	et	al.,	2014;	Stamp	et	al.,	2018).
Next,	the	authors	identify	somatic	mutations	that	bias	competition	between	ISCs.	STAG2,	which	forms	part	of	the	cohesion	complex	and	is	a	known	tumor	suppressor,	confers	a	competitive	advantage	over	non-mutant	ISCs.	The
authors	suggest	the	diminished	ratio	of	WPC	to	PPC	are	indicative	of	increased	competitive	advantage,	meaning	that	STAG2	mutant	clones	are	almost	certain	(p	=	0.99)	to	outcompete	their	non-mutant	counterparts.	Critically,	this	is
the	first	quantification	of	intra-cryptal	mutation-driven	bias	in	human	colonic	ISCs	(Figure	1).
Intra-cryptal	competition	is	just	one	way	for	mutations	to	achieve	epithelial	colonization.	As	such,	the	authors	investigate	crypt	fission	as	an	alternative	means	to	permit	mutant	clone	expansion.	Basal	crypt	fission	rates	for
neutral	mutations	were	calculated	as	∼0.7%/yr.	Interestingly,	the	crypt	fission	rate	measured	in	STAG2	mutant	crypts	was	3-fold	higher	(2.15%/yr)	than	that	observed	in	neutral	mutant	crypts.
Previous	reports	have	noted	the	presence	of	KRAS	mutant	crypts	in	otherwise	morphologically	normal	human	colon.	However,	the	authors	argue	that	without	a	substantial	competitive	advantage,	KRAS	mutations	would	go
undetected	because	of	the	markedly	low	mutation	rate.	Using	targeted	sequencing	to	detect	KRAS	mutations,	the	authors	conclude	that	intra-cryptal	fixation	cannot	account	for	the	quantity	of	KRAS	mutant	cells.	Instead,	the	authors
Figure	1	Somatic	Mutations	Can	Bias	Clonal	Dynamics	of	Human	Colonic	Crypts
Cross-sectional	schematic	of	human	colonic	crypts	showing	intestinal	stem	cell	(ISC)	clonal	dynamics.	In	the	presence	of	neutral	somatic	mutations	(mPAS+),	all	functional	ISCs	have	an	equal	chance	of	expanding	(curved	arrows)	or	being	replaced	(∗)
from	the	crypt.	Over	time,	the	number	of	mutant	functional	ISCs	(Ncrypt)	decreases	as	some	are	replaced	by	wild-type	neighbors	and	lost.	However,	the	mutant	clones	that	remain	trend	toward	clonal	fixation,	which	occurs	over	many	years.	Pro-oncogenic
mutations,	such	as	STAG2	or	KRASG12D,	bias	ISC-competition	and	increase	the	frequency	of	crypt	fission	and	clonal	patch	expansion.
propose	that	a	10-fold	increase	in	KRAS	mutant	crypt	fission	can	account	for	the	observed	biological	dataset	(Figure	1).	This	would	result	in	large	patches	of	KRAS	mutant	crypts	in	otherwise	non-neoplastic	tissue,	confirming	previous
reports	of	increased	crypt	fission	in	Kras	mutant	mouse	epithelium	(Snippert	et	al.,	2014).
Importantly,	Nicholson	et	al.	(2018)	define	basal	metrics	to	describe	stem-cell	competition	within	the	human	colon.	While	this	is	not	the	first	report	of	human	colonic	stem	cell	dynamics,	it	is	the	first	to	quantify	the	effect	of
advantageous	mutations	upon	both	 intra-cryptal	dynamics	and	crypt	 fission.	Compared	with	neutral	mutations,	 the	authors	conclude	that	over	a	 lifetime,	the	pro-oncogenic	mutations	KRAS	and	STAG2	have	a	155-fold	and	13-fold
greater	expansion	coefficient,	respectively.
The	study	from	Nicholson	et	al.	(2018)	has	 implications	for	the	ISC	and	cancer	fields.	For	 instance,	 the	human	colon,	rather	than	being	ubiquitously	composed	of	non-mutant	cells,	 is	 likely	to	be	a	mosaic	of	mutant	clonal
patches,	which	will	shape	the	subsequent	interpretation	of	mutant	phenotypes.	Similarly,	founding	mutations	may	influence	the	fitness	of	secondary	mutations	that	occur	within	the	same	clonal	patch.	For	example,	clonal	fixation	of
APC	mutant	cells	may	differ	profoundly	if	a	pre-existing	KRAS	mutation	is	present.	This	may	potentiate	rapid	expansion	of	neoplastic	clones,	in	line	with	recent	reports	describing	tumor	mutation	hierarchy	and	the	so-called	“big	bang”
model	(Roerink	et	al.,	2018;	Sottoriva	et	al.,	2015).	Therefore,	the	colon	and	other	epithelia	may	mimic	the	skin,	where	multiple	mutations	are	required	to	subvert	homeostatic-constraint	mechanisms.	For	example,	we	observed	that	loss
of	Tgfbr1	drove	rapid	invasive	carcinoma	when	combined	with	KrasG12D,	whereas	KrasG12D	alone	had	little	phenotype	and	failed	to	drive	cancer	(Cammareri	et	al.,	2016).
In	the	future,	it	will	be	interesting	to	assess	if	any	common	colorectal	cancer	risk	alleles	or	lifestyle	predispositions	impinge	on	human-stem-cell	dynamics.	Moreover,	given	the	sluggish	pace	of	clonal	fixation,	this	could	provide
a	promising	therapeutic	window	to	eradicate	premalignant	clones	prior	to	fixation.
Declaration	of	Interests
The	authors	declare	no	competing	interests.
References
Baker	A.-M.,	Cereser	B.,	Melton	S.,	Fletcher	A.G.,	Rodriguez-Justo	M.,	Tadrous	P.J.,	Humphries	A.,	Elia	G.,	McDonald	S.A.C.,	Wright	N.A.,	et	al.,	Quantification	of	crypt	and	stem	cell	evolution	in	the	normal	and	neoplastic	human
colon,	Cell	Rep.	8,	2014,	940–947.
Cammareri	P.,	Rose	A.M.,	Vincent	D.F.,	Wang	J.,	Nagano	A.,	Libertini	S.,	Ridgway	R.A.,	Athineos	D.,	Coates	P.J.,	McHugh	A.,	et	al.,	Inactivation	of	TGFβ	receptors	in	stem	cells	drives	cutaneous	squamous	cell	carcinoma,	Nat.
Commun.	7,	2016,	12493.
Huels	D.J.,	Bruens	L.,	Hodder	M.C.,	Cammareri	P.,	Campbell	A.D.,	Ridgway	R.A.,	Gay	D.M.,	Solar-Abboud	M.,	Faller	W.J.,	Nixon	C.,	et	al.,	Wnt	ligands	influence	tumour	initiation	by	controlling	the	number	of	intestinal	stem	cells,
Nat.	Commun.	9,	2018,	1132.
Kozar	S.,	Morrissey	E.,	Nicholson	A.M.,	van	der	Heijden	M.,	Zecchini	H.I.,	Kemp	R.,	Tavaré	S.,	Vermeulen	L.	and	Winton	D.J.,	Continuous	clonal	labeling	reveals	small	numbers	of	functional	stem	cells	in	intestinal	crypts	and
adenomas,	Cell	Stem	Cell	13,	2013,	626–633.
Nicholson	A.M.,	Olpe	C.,	Hoyle	A.,	Thorsen	A.-S.,	Rus	T.,	Colombe	M.,	Brunton-Sim	R.,	Kemp	R.,	Marks	K.,	Quirke	P.,	et	al.,	Fixation	and	spread	of	somatic	mutations	in	adult	human	colonic	epithelium,	Cell	Stem	Cell	22,	2018,
this	issue,	■■■–■■■.
Roerink	S.F.,	Sasaki	N.,	Lee-Six	H.,	Young	M.D.,	Alexandrov	L.B.,	Behjati	S.,	Mitchell	T.J.,	Grossmann	S.,	Lightfoot	H.,	Egan	D.A.,	et	al.,	Intra-tumour	diversification	in	colorectal	cancer	at	the	single-cell	level,	Nature	556,	2018,
457–462.
Snippert	H.J.,	Schepers	A.G.,	van	Es	J.H.,	Simons	B.D.	and	Clevers	H.,	Biased	competition	between	Lgr5	intestinal	stem	cells	driven	by	oncogenic	mutation	induces	clonal	expansion,	EMBO	Rep.	15,	2014,	62–69.
Sottoriva	A.,	Kang	H.,	Ma	Z.,	Graham	T.,	Salomon	M.,	Zhao	J.,	Marjoram	P.,	Siegmund	K.,	Press	M.,	Shibata	D.	and	Curtis	C.,	A	Big	Bang	model	of	human	colorectal	tumor	growth,	Nat	Genet	47,	2015,	ng.3214.
Stamp	C.,	Zupanic	A.,	Sachdeva	A.,	Stoll	E.,	Shanley	D.,	Mathers	J.,	Kirkwood	T.,	Heer	R.,	Simons	B.,	Turnbull	D.	and	Greaves	L.,	Predominant	Asymmetrical	Stem	Cell	Fate	Outcome	Limits	the	Rate	of	Niche	Succession	in
Human	Colonic	Crypts,	EBioMedicine	2018,	https://doi.org/10.1016/j.ebiom.2018.04.017,	Published	online	April	25,	2018.
Vermeulen	L.	and	Snippert	H.J.,	Stem	cell	dynamics	in	homeostasis	and	cancer	of	the	intestine,	Nat.	Rev.	Cancer	14,	2014,	468–480.
Vermeulen	L.,	Morrissey	E.,	van	der	Heijden	M.,	Nicholson	A.M.,	Sottoriva	A.,	Buczacki	S.,	Kemp	R.,	Tavaré	S.	and	Winton	D.J.,	Defining	stem	cell	dynamics	in	models	of	intestinal	tumor	initiation,	Science	342,	2013,	995–998.
